534% Revenue Surge Unveiled By Israeli CBD-Focused Pharma Company, Exceeding Expectations

CEO Iris Bincovich outlines strategic pursuits, including FDA approval for LPT CBD-loaded liposome platform. “We are very pleased with our performance in 2023, closing the year with a strong fourth …